• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty® COVID-19 vaccine.

作者信息

Giménez Estela, Alberola Juan, Torres Ignacio, Albert Eliseo, Alcaraz María Jesús, Botija Pilar, Amat Paula, Remigia María José, Beltrán María José, Rodado Celia, Huntley Dixie, Olea Beatriz, Navarro David

机构信息

Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Av. Blasco Ibáñez 17, Valencia 46010, Spain.

Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.

出版信息

J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.10.026. Epub 2021 Nov 2.

DOI:10.1016/j.jinf.2021.10.026
PMID:34740744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8562042/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f328/8562042/6be6fee496e0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f328/8562042/01cec5274d7d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f328/8562042/6be6fee496e0/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f328/8562042/01cec5274d7d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f328/8562042/6be6fee496e0/gr2_lrg.jpg

相似文献

1
Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty® COVID-19 vaccine.接受完整剂量的Comirnaty® COVID-19疫苗后，疗养院居民中SARS-CoV-2免疫反应的演变。
J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.10.026. Epub 2021 Nov 2.
2
B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.科维希德® COVID-19 疫苗在养老院居民中引发的 B 细胞和 T 细胞免疫应答。
Clin Microbiol Infect. 2021 Nov;27(11):1672-1677. doi: 10.1016/j.cmi.2021.06.013. Epub 2021 Jun 24.
3
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents.在养老院居民中使用 Comirnaty® COVID-19 疫苗全剂量接种后对 SARS-CoV-2 的免疫应答。
Clin Microbiol Infect. 2022 Feb;28(2):279-284. doi: 10.1016/j.cmi.2021.09.031. Epub 2021 Oct 5.
4
SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.辉瑞疫苗接种中期，养老院居民感染新冠病毒德尔塔变异株。
J Med Virol. 2022 Aug;94(8):3776-3782. doi: 10.1002/jmv.27799. Epub 2022 Apr 27.
5
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine.接种第三剂科兴新冠疫苗后养老院居民中严重急性呼吸综合征冠状病毒 2 型适应性免疫
Clin Infect Dis. 2022 Aug 24;75(1):e865-e868. doi: 10.1093/cid/ciac223.
6
SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.Omicron BA.1 变异株突破感染同源第三剂 Comirnaty® COVID-19 疫苗后的养老院居民：寻找保护相关因素。
J Med Virol. 2022 Sep;94(9):4216-4223. doi: 10.1002/jmv.27867. Epub 2022 May 25.
7
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2（Delta）变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络，2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
8
T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.养老院居民中初次接种和加强接种 SARS-CoV-2 信使 RNA 疫苗后的 T 细胞介导的反应。
J Am Med Dir Assoc. 2023 Feb;24(2):140-147.e2. doi: 10.1016/j.jamda.2022.11.024. Epub 2022 Dec 7.
9
Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status.有既往感染史的养老院居民接种两剂 Comirnaty 疫苗后体液抗 SARS-CoV-2 免疫应答。
Vaccine. 2022 Jan 24;40(3):531-535. doi: 10.1016/j.vaccine.2021.11.086. Epub 2021 Dec 3.
10
Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the comirnaty COVID-19 vaccine in nursing home residents.科维希尔德 COVID-19 疫苗在养老院居民中引发的针对 SARS-CoV-2 关切变异株的中和抗体。
Sci Rep. 2022 Mar 8;12(1):3788. doi: 10.1038/s41598-022-07849-2.

引用本文的文献

1
Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination.针对基于武汉株 mRNA 加强针接种后老年疗养院居民中靶向 SARS-CoV-2 奥密克戎 XBB.1.5 的 Spike 蛋白的功能性抗体反应。
Sci Rep. 2024 May 24;14(1):11896. doi: 10.1038/s41598-024-62874-7.
2
Longitudinal Analysis of Nursing Home Residents' T-Cell Responses After SARS-CoV-2 mRNA Vaccinations Shows Influence of Biological Sex and Infection History.养老院居民接种 SARS-CoV-2 mRNA 疫苗后 T 细胞反应的纵向分析显示了生物性别和感染史的影响。
J Infect Dis. 2024 Sep 23;230(3):635-644. doi: 10.1093/infdis/jiae234.
3

本文引用的文献

1
Considerations in boosting COVID-19 vaccine immune responses.增强新冠病毒疫苗免疫反应的考量因素。
Lancet. 2021 Oct 9;398(10308):1377-1380. doi: 10.1016/S0140-6736(21)02046-8. Epub 2021 Sep 14.
2
Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study.BNT162b2疫苗接种六个月后抗体反应的动态变化：一项纵向前瞻性研究。
Lancet Reg Health Eur. 2021 Nov;10:100208. doi: 10.1016/j.lanepe.2021.100208. Epub 2021 Sep 6.
3
B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.
Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects.
BNT162b2 疫苗接种 6 个月后 COVID-19 初治和 COVID-19 既往感染人群抗 S1/S2 IgG 血清水平下降率。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2060018. doi: 10.1080/21645515.2022.2060018. Epub 2022 May 5.
4
SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine.两剂辉瑞-BioNTech 新冠疫苗接种 8 个月后，养老院居民的 SARS-CoV-2 适应性免疫。
J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.02.035. Epub 2022 Mar 2.
科维希德® COVID-19 疫苗在养老院居民中引发的 B 细胞和 T 细胞免疫应答。
Clin Microbiol Infect. 2021 Nov;27(11):1672-1677. doi: 10.1016/j.cmi.2021.06.013. Epub 2021 Jun 24.
4
Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers.未感染过新冠病毒的疫苗接种者体内抗体水平下降：对医护人员中mRNA-1273疫苗进行的持续免疫原性和疗效监测的三个月中期分析结果
J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.06.017. Epub 2021 Jun 20.
5
One year later: SARS-CoV-2 immune response and vaccination of healthcare workers post-infection.一年后：感染后医护人员的新冠病毒免疫反应及疫苗接种情况
J Infect. 2021 Sep;83(3):381-412. doi: 10.1016/j.jinf.2021.06.016. Epub 2021 Jun 18.
6
Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.接种mRNA疫苗和未接种疫苗的养老院居民中SARS-CoV-2感染事件
N Engl J Med. 2021 Jul 29;385(5):474-476. doi: 10.1056/NEJMc2104849. Epub 2021 May 19.
7
Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study.BNT162b2 疫苗在体弱或残疾的疗养院居民中的免疫原性：COVID-A 研究。
J Am Geriatr Soc. 2021 Jun;69(6):1441-1447. doi: 10.1111/jgs.17153. Epub 2021 Apr 2.
8
Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation.抗SARS-CoV-2抗体的定量检测：分析与临床评估
J Clin Microbiol. 2021 Mar 19;59(4). doi: 10.1128/JCM.03149-20.